£795.00

The 2023-2028 World Outlook for Uterine Cancer Treatments and Diagnostics

Price data last checked 90 day(s) ago - refreshing...

View at Amazon

Price History & Forecast

Last 1 days • 1 data points (No recent data available)

Historical
Generating forecast...
Not enough data points to display chart (need at least 2 points)

Price Distribution

Price distribution over 1 days • 1 price levels

Days at Price
1 day 0 0 1 1 1 £795 Days at Price

Price Analysis

Most common price: £795 (1 days, 100.0%)

Price range: £795 - £795

Price levels: 1 different prices over 1 days

Product Specifications

Format
Paperback
Domain
Amazon UK
Release Date
10 May 2022
Listed Since
15 May 2022

Similar Products You Might Like

The 2023-2028 Outlook for Uterine Cancer Therapeutics and Diagnostics in the United States
98% match

The 2023-2028 Outlook for Uterine Cancer Therapeutics and Diagnostics in the United States

£520.00 21 Jan 2026
The 2023-2028 World Outlook for Cervical Cancer Treatments
98% match

The 2023-2028 World Outlook for Cervical Cancer Treatments

£795.00 30 Jan 2026
The 2023-2028 Outlook for Uterine Cancer Therapeutics and Diagnostics in India
98% match

The 2023-2028 Outlook for Uterine Cancer Therapeutics and Diagnostics in India

£515.00 14 Jan 2026
2023-2028 Outlook for Endometrial Cancer Treatments in US
98% match

2023-2028 Outlook for Endometrial Cancer Treatments in US

£520.00 03 Mar 2026
The 2023-2028 World Outlook for Chemotherapy for Endometrial Cancers
97% match

The 2023-2028 World Outlook for Chemotherapy for Endometrial Cancers

£795.00 02 Apr 2026
The 2023-2028 Outlook for Cervical Cancer Treatments in the United States
97% match

The 2023-2028 Outlook for Cervical Cancer Treatments in the United States

£520.00 26 Jan 2026
The 2023-2028 Outlook for Gynecologic Oncology in the United States
97% match

The 2023-2028 Outlook for Gynecologic Oncology in the United States

£520.00 01 Feb 2026
The 2023-2028 Outlook for Endometrial Cancer Treatments in India
97% match

The 2023-2028 Outlook for Endometrial Cancer Treatments in India

£515.00 10 Mar 2026
The 2023-2028 World Outlook for Women's Diagnostic Breast Cancer Testing
96% match

The 2023-2028 World Outlook for Women's Diagnostic Breast Cancer Testing

£795.00 28 Mar 2026
The 2023-2028 Outlook for Cervical Cancer Treatments in India
96% match

The 2023-2028 Outlook for Cervical Cancer Treatments in India

£515.00 25 Jan 2026
The 2023-2028 World Outlook for Basal Cell Carcinoma Treatments
96% match

The 2023-2028 World Outlook for Basal Cell Carcinoma Treatments

£795.00 06 Jan 2026
The 2023-2028 Outlook for Uterine Cancer Therapeutics and Diagnostics in China
96% match

The 2023-2028 Outlook for Uterine Cancer Therapeutics and Diagnostics in China

£495.00 20 Mar 2026
The 2023-2028 World Outlook for Non-Hodgkin Lymphoma Treatments
96% match

The 2023-2028 World Outlook for Non-Hodgkin Lymphoma Treatments

£795.00 13 Dec 2025
The 2023-2028 World Outlook for Carcinoembryonic Antigen
96% match

The 2023-2028 World Outlook for Carcinoembryonic Antigen

£795.00 12 Jan 2026
The 2023-2028 Outlook for Breast Cancer Diagnostic Products in the United States
96% match

The 2023-2028 Outlook for Breast Cancer Diagnostic Products in the United States

£520.00 20 Jan 2026
The 2023-2028 Outlook for Bile Duct Cancer (Cholangiocarcinoma) Treatments in the United States
96% match

The 2023-2028 Outlook for Bile Duct Cancer (Cholangiocarcinoma) Treatments in the United States

£520.00 10 Jan 2026
The 2023-2028 Outlook for Uterine Cancer Therapeutics and Diagnostics for US Zip Codes
96% match

The 2023-2028 Outlook for Uterine Cancer Therapeutics and Diagnostics for US Zip Codes

£490.00 23 Jan 2026
The 2023-2028 Outlook for Cancer Supportive Care in the United States
96% match

The 2023-2028 Outlook for Cancer Supportive Care in the United States

£520.00 24 Jan 2026
The 2023-2028 World Outlook for Colorectal Cancer Drugs
96% match

The 2023-2028 World Outlook for Colorectal Cancer Drugs

£795.00 12 Feb 2026
The 2023-2028 Outlook for Basal Cell Carcinoma Treatments in the United States
96% match

The 2023-2028 Outlook for Basal Cell Carcinoma Treatments in the United States

£520.00 12 Jan 2026
The 2023-2028 Outlook for Neuroendocrine Tumor Treatments in the United States
96% match

The 2023-2028 Outlook for Neuroendocrine Tumor Treatments in the United States

£520.00 05 Feb 2026
The 2023-2028 Outlook for Cancer Supportive Care Drugs in the United States
96% match

The 2023-2028 Outlook for Cancer Supportive Care Drugs in the United States

£520.00 22 Jan 2026
The 2023-2028 World Outlook for Tumor-Specific Antigen
96% match

The 2023-2028 World Outlook for Tumor-Specific Antigen

£795.00 08 Feb 2026
The 2023-2028 Outlook for Cancer Screenings in the United States
96% match

The 2023-2028 Outlook for Cancer Screenings in the United States

£520.00 15 Jan 2026